Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.696
+0.031 (4.66%)
At close: Nov 22, 2024, 4:00 PM
0.690
-0.005 (-0.78%)
After-hours: Nov 22, 2024, 5:39 PM EST

Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $157.63 million. The enterprise value is $34.22 million.

Market Cap 157.63M
Enterprise Value 34.22M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

Gossamer Bio has 226.60 million shares outstanding. The number of shares has increased by 88.97% in one year.

Current Share Class 226.60M
Shares Outstanding 226.60M
Shares Change (YoY) +88.97%
Shares Change (QoQ) -5.11%
Owned by Insiders (%) 3.17%
Owned by Institutions (%) 63.71%
Float 188.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.49
Forward PS n/a
PB Ratio 2.91
P/TBV Ratio 2.91
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.32
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.74, with a Debt / Equity ratio of 3.76.

Current Ratio 6.74
Quick Ratio 6.53
Debt / Equity 3.76
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.23

Financial Efficiency

Return on equity (ROE) is -90.26% and return on invested capital (ROIC) is -13.58%.

Return on Equity (ROE) -90.26%
Return on Assets (ROA) -11.24%
Return on Capital (ROIC) -13.58%
Revenue Per Employee $780,163
Profits Per Employee -$530,719
Employee Count 135
Asset Turnover 0.30
Inventory Turnover n/a

Taxes

In the past 12 months, Gossamer Bio has paid $3.30 million in taxes.

Income Tax 3.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -8.41% in the last 52 weeks. The beta is 1.96, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y) 1.96
52-Week Price Change -8.41%
50-Day Moving Average 0.91
200-Day Moving Average 0.93
Relative Strength Index (RSI) 25.98
Average Volume (20 Days) 966,815

Short Selling Information

The latest short interest is 6.30 million, so 2.78% of the outstanding shares have been sold short.

Short Interest 6.30M
Short Previous Month 6.95M
Short % of Shares Out 2.78%
Short % of Float 3.35%
Short Ratio (days to cover) 8.17

Income Statement

In the last 12 months, Gossamer Bio had revenue of $105.32 million and -$71.65 million in losses. Loss per share was -$0.32.

Revenue 105.32M
Gross Profit 105.32M
Operating Income -62.82M
Pretax Income -172.58M
Net Income -71.65M
EBITDA -61.80M
EBIT -62.82M
Loss Per Share -$0.32
Full Income Statement

Balance Sheet

The company has $327.03 million in cash and $203.63 million in debt, giving a net cash position of $123.41 million or $0.54 per share.

Cash & Cash Equivalents 327.03M
Total Debt 203.63M
Net Cash 123.41M
Net Cash Per Share $0.54
Equity (Book Value) 54.14M
Book Value Per Share 0.24
Working Capital 293.18M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.41M
Capital Expenditures n/a
Free Cash Flow -1.41M
FCF Per Share -$0.01
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -59.64% and -68.03%.

Gross Margin 100.00%
Operating Margin -59.64%
Pretax Margin -64.89%
Profit Margin -68.03%
EBITDA Margin -58.68%
EBIT Margin -59.64%
FCF Margin n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -88.97%
Shareholder Yield -88.97%
Earnings Yield -45.45%
FCF Yield -0.90%

Analyst Forecast

The average price target for Gossamer Bio is $9.20, which is 1,222.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.20
Price Target Difference 1,222.60%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Gossamer Bio has an Altman Z-Score of -3.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.81
Piotroski F-Score 2